MSCI index

Vaccine maker AIM Vaccine said on Monday it expects to report a net loss of 1.25 billion yuan to 1.38 billion yuan for last year, roughly quadruple its loss from 2022.

FAST NEWS: AIM Vaccine’s loss balloons

The latest: Vaccine maker AIM Vaccine Co. Ltd. (6660.HK) said on Monday it expects to report a net loss of 1.25 billion yuan ($174 million) to 1.38 billion yuan for last…
6660.HK

Recent Articles

RELATED ARTICLES

  1. Clover Biopharmaceuticals Ltd. faces a potentially damaging fight
    Dispute over Covid vaccines casts doubt on Clover Bio recovery
    2197.HK
  2. Zhengye Biotech’s ‘pet-sized’ IPO leaves plenty of room for more fundraising
    ZYBT.US
  3. Everest Medicines drives growth with AI-powered mRNA pipeline
    1952.HK
  4. WuXi Biologics sells vaccine plant as new U.S. law looms
    2269.HK
  5. Why aim small? 51World Digital Twin sets its sights on cloning Earth
  6. Everest Medicines eyes mRNA tumor vaccines as drug valuations rebound
    1952.HK
  7. Country Garden’s debt restructure hinges on stabilizing property market
    2007.HK
Discover hidden China stock gems in our weekly newsletter

Follow us

Facebook Twitter Linkedin Weixin Weibo Youtube

Subscribe to Our Free eNewsletter

Subscribe

Check out our content with some of our syndication partners

factiva